The Palico Private Equity Fund Marketplace
Omega Fund Management is a private equity general partner firm headquartered in London, United Kingdom and has other offices in
VC-backed Editas Medicine, a company that aims to treat diseases through gene editing, has raised $94.4m through its IPO.
Editas Medicine, a genome editing firm, has raised $120m in Series B funding led by Boris Nikolic, with the participation of others VCs.
Kezar Life Sciences, a CA-based biopharmaceutical firm, completed a $23m Series A financing from Omega Funds, Aju IB Investment and others.
Read more news concerning Omega Fund Management
A sampling of Omega Fund Management portfolio companies:
View all of the investments in their portfolio
Registration is fast, free and easy
Already a member?